This article is available to subscribers. Subscribe now. Already have an account? Sign in

CorrespondenceFree Preview

Indigenous Australians and Living Kidney Donation

To the Editor: Indigenous Australians comprise 2.5% of the total population of Australia, but like other minority groups worldwide, rates of chronic kidney disease are higher among this indigenous group than among the general population. Transplantation remains the preferred form of renal-replacement therapy, and the use of living donors maximizes transplantation rates with a generally minimal long-term effect on donors.1 However, the consequences of the use of this strategy in indigenous Australians are unclear, given the likelihood of a family or community history of chronic kidney disease in potential donors.We performed a retrospective analysis of all living kidney donors . . .

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Natasha M. Rogers, M.D.
Queen Elizabeth Hospital, Adelaide, SA, Australia

Paul D. Lawton, M.D.
Royal Darwin Hospital, Darwin, NT, Australia

Matthew D. Jose, M.D., Ph.D.
Menzies Research Institute, Hobart, TAS, Australia

Funding and Disclosures

Supported by a CellCept Australia Research Grant from Roche Australia.

Dr. Rogers reports receiving grant support from Roche; and Dr. Jose, receiving consulting fees from Novartis and grant support from Roche.

No other potential conflict of interest relevant to this letter was reported.

Print Subscriber? Activate your online access.